SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Chromogranin A promotes the pathological conversion of α-synuclein at the synapse in Parkinson's disease.

Cell Rep · 2025-11-15

DOI: 10.1016/j.celrep.2025.116562PMID: 41241941

Check source for accessResearch Support, Non-U.S. Gov't; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

α-Synuclein (αSyn) aggregation is a prominent hallmark of Parkinson's disease (PD), yet the initial cellular mechanisms are not well understood. In this study, we show that a single day of αSyn preformed fibril (PFF) administration leads to prominent localization of phosphorylated αSyn (p-αSyn) within the pre-synapse of primary neurons. Overexpressing chromogranin A (CgA), which is found in large dense-core vesicles (LDCVs), enhances αSyn aggregation in various neuronal and PD mouse models. Subsequently, by incubating αSyn with CgA, we create a unique strain of fibrils displaying smaller length, stronger resistance to proteolytic digestion, and higher amyloidogenic properties compared to conventional αSyn fibrils. Additionally, CgA knockout alleviates dendritic spine loss and synaptic dysfunction induced by αSyn PFF and slows down the spread of pathological inclusions in vivo. Collectively, our findings demonstrate how the intra-vesicular matrix protein CgA triggers and facilitates early seeding events leading to subsequent toxicity caused by αSyn pathology.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.